CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Vir Biotechnology announced promising results Wednesday for a pair of cancer treatments, and Vir stock catapulted by double ...

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation ...

Francis Medical Inc., a Twin Cities med-tech manufacturer that's developing a way to treat prostrate and other cancers with water vapor, said Tuesday it raised $80 million in its latest equity funding ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The ...

In 2012, Alfred was diagnosed with advanced prostate cancer which had already spread to his bones. As surgery wouldn’t have been effective, Alfred enrolled in the Cancer Research UK-funded STAMPEDE ...

HRS-1167 is under clinical development by Merck and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC).

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description: ...